Navigation Links
Depomed To Report Second Quarter Fiscal Year 2014 Financial Results On Wednesday, August 6, 2014
Date:7/25/2014

NEWARK, Calif., July 25, 2014 /PRNewswire/ -- Depomed, Inc. (NASDAQ: DEPO) today announced that it will release second quarter fiscal year 2014 financial results after the market closes on Wednesday, August 6, 2014. The Company will host a conference call beginning at 4:30 pm EDT, 1:30 pm PDT to discuss its results.

Participants can access the call by dialing 877-317-6789 (United States) or 412-317-6789 (international). The conference call will also be available via a live webcast on the investor relations section of Depomed's website at http://www.depomed.com. Access the website 15 minutes prior to the start of the call to download and install any necessary audio software. An archived webcast replay will be available on the Company's website for three months.

About Depomed

Depomed is a specialty pharmaceutical company that commercializes products for pain and neurology related disorders.  Gralise® (gabapentin) is a once-daily treatment approved for the management of postherpetic neuralgia. CAMBIA® (diclofenac potassium for oral solution) is a non-steroidal anti-inflammatory drug indicated for acute treatment of migraine attacks with or without aura in adults (18 years of age or older). Zipsor® (diclofenac potassium) Liquid Filled Capsules is a non-steroidal anti-inflammatory drug indicated for relief of mild to moderate acute pain in adults.  Lazanda® (fentanyl) Nasal Spray is an intranasal fentanyl drug used to manage breakthrough pain in adults (18 years of age or older) who are already routinely taking other opioid pain medicines around-the-clock for cancer pain. Gralise and various partner product candidates are formulated with Depomed's proven, proprietary Acuform®<
'/>"/>

SOURCE Depomed, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Depomed Announces Receipt of $1 million Milestone Payment From Ironwood Pharmaceuticals, Inc.
2. Depomed To Present At Jefferies 2012 Global Health Care Conference
3. Depomed Announces Filing Of Shelf Registration To Replace Existing Shelf
4. Depomed To Present At JMP Securities 7th Annual Healthcare Conference
5. Depomed To Report Second Quarter Fiscal Year 2012 Financial Results On Thursday, August 2, 2012
6. Depomed To Present At Stifel Nicolaus 2012 Healthcare Conference
7. Depomed To Present At Morgan Stanley 2012 Healthcare Conference
8. Depomed To Present At UBS Global Life Sciences Conference
9. Depomed To Report Third Quarter Fiscal Year 2012 Financial Results On Monday, November 5, 2012
10. Depomed Reports Third Quarter Financial Results
11. Depomed To Present At Lazard 2012 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... Aug. 4, 2015 BioElectronics Corporation (OTC ... Musculoskeletal Pain Therapy medical devices, announced today that ... ActiPatch 7-day trial device has been published in ... Management http://www.futuremedicine.com/doi/full/10.2217/PMT.15.35 .  More than 5,000 ... submitted an assessment.  Chronic pain ...
(Date:8/4/2015)... Research and Markets ... Jain PharmaBiotech,s new report "Animal Biotechnology - ... This report describes and evaluates animal ... pharmaceuticals as well as improvement in food production. ... application of biotechnology to manage genetic disorders and ...
(Date:8/4/2015)... Therapeutics, Inc. ("Mirati") (NASDAQ: MRTX ),  a targeted oncology ... be presenting at the 2015 Wedbush PacGrow Healthcare Conference on ... PT) in New York . Charles ... will provide a corporate overview. A live audio ... page of Mirati,s corporate website at www.mirati.com . A ...
Breaking Medicine Technology:BioElectronics' Landmark 5,000+ Chronic Pain Patient Study Published in Pain Management Medical Journal 2Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 2Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 3Mirati Therapeutics To Present At The 2015 Wedbush PacGrow Healthcare Conference 2Mirati Therapeutics To Present At The 2015 Wedbush PacGrow Healthcare Conference 3
... SPRING, Md., April 28, 2011 The U.S. ... acetate) in combination with prednisone (a steroid) to ... who have received prior docetaxel (chemotherapy). ... cancer, the male sex hormone testosterone stimulates prostate ...
... Sciences Inc. (PSI), a leading pharmaceutical CRO, and ... ethylene vinyl acetate (EVA) into pharmaceutical applications, are ... devices.  Building on years of collaboration, Particle Sciences ... provide Particle Sciences with preferred access to VitalDose™ ...
Cached Medicine Technology:FDA Approves Zytiga for Late-Stage Prostate Cancer 2FDA Approves Zytiga for Late-Stage Prostate Cancer 3Particle Sciences and Celanese EVA Performance Polymers Collaborate to Accelerate Drug-Eluting Device Combinations 2Particle Sciences and Celanese EVA Performance Polymers Collaborate to Accelerate Drug-Eluting Device Combinations 3
(Date:8/4/2015)... ... August 04, 2015 , ... PerceptiMed, ... Richard Carmona, M.D., M.P.H., FACS, to its Board of Directors effective August 1, ... lives," Dr. Carmona said. "I strongly believe in the mission of the company ...
(Date:8/4/2015)... ... August 04, 2015 , ... Seedstock’s ... for Nov. 3 – 4, 2015, at UC San Diego, will explore innovations ... improve food access, and manage resources efficiently against the dueling backdrop of a ...
(Date:8/4/2015)... Mount Horeb, WI (PRWEB) , ... August 04, 2015 , ... ... newly released video on the subject, Renew Man™ is standing up as a voice ... a 15-year veteran of the healthy aging industry with special experience and expertise in ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... They say ... better understand certain health conditions, pictures and medical art can be essential. StayWell, a ... providers. , Krames Patient Education solutions have been used by physicians and other ...
(Date:8/4/2015)... ... August 04, 2015 , ... Discovia, ... entities, today announced that John Munro, a 15-year veteran of the eDiscovery services ... Services Operations. , “I am thrilled to join Discovia at this important point ...
Breaking Medicine News(10 mins):Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 2Health News:Dr. Richard Carmona, 17th Surgeon General of the United States, Joins PerceptiMed, Inc.’s Board of Directors 3Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 2Health News:Diversity of Urban and Hydroponic Farms of the Future to Highlight Seedstock Annual Conference Field Trip 3Health News:New Video from Renew Man™ Raises Awareness of the Right Way to Correct Low Testosterone 2Health News:New Video from Renew Man™ Raises Awareness of the Right Way to Correct Low Testosterone 3Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 2Health News:StayWell Offers Instant Downloads, Licensing of Medical Art to Improve Patient Education 3Health News:John Munro Joins eDiscovery Leader Discovia as Vice President of Managed Services Operations 2Health News:John Munro Joins eDiscovery Leader Discovia as Vice President of Managed Services Operations 3
... U.S. News & World Report has ranked,Cincinnati Children,s ... United States in general pediatrics in the 2008 edition ... is,the highest Cincinnati Children,s has ever received from U.S. ... we owe a great debt of thanks,to the thousands ...
... WASHINGTON, May 30 The National Alliance on,Mental ... for her,contributions to public education about mental illness ... 2008., NAMI executive director Mike Fitzpatrick made ... in which he discussed the premiere of,two ...
... May 30 The following is being issued,by the Federation ... physician scientists from 58 countries across the globe, What: ... When: Wednesday, June 4-Monday, June 9, Where: Boston Marriott ... accelerate science that improves patient care, Wednesday, June 4, ...
... is Dec. 31, but FDA urges asthma patients to ... (HealthDay News) -- Asthma inhalers that contain the drug ... harm the ozone layer. And these inhalers won,t be ... urging patients to switch to alternative inhalers now. , ...
... hardest hit ... areas of the country, WILMINGTON, ... homeless after Cyclone Nargis swept through Myanmar. Malteser,International has been providing ... of Labutta in the Irrawaddy Delta. Present in,Myanmar since 2001, Malteser ...
... Indiana experienced a 50 percent membership ... growth since 2007, ... this 14-year-old, not-for-profit,Indiana managed health care plan -- surpassing the 300,000 mark ... 2007, the,company has also grown its employee base by 182 percent -- ...
Cached Medicine News:Health News:U.S. News Ranks Cincinnati Children's Among Top Three U.S. Children's Hospitals 2Health News:U.S. News Ranks Cincinnati Children's Among Top Three U.S. Children's Hospitals 3Health News:NAMI Blog: PBS, MTV and Jane Pauley 2Health News:World-Renowned Scientists to Lead Immunology Course 2Health News:World-Renowned Scientists to Lead Immunology Course 3Health News:World-Renowned Scientists to Lead Immunology Course 4Health News:Ozone-Depleting Inhalers Being Phased Out 2Health News:Ozone-Depleting Inhalers Being Phased Out 3Health News:More Than 78,000 are Dead and Millions are Homeless After Cyclone Nargis Swept Through Myanmar 2Health News:MDwise Enrollment Exceeds 300,000 Members 2
...
ENDOlap™ suction and irrigation trumpet valves...
... Clinicians are demanding smaller, higher ... their clinical and operational challenges. The ... a powerful architecture for superb High ... mobility and ease-of-use; and a versatile ...
... The Dimension Vista 1500 integrated ... nephelometry, IMT (integrated multisensor technology) ... design will integrate analysis of ... drugs-of-abuse, therapeutic drugs, immunosuppressive drugs, ...
Medicine Products: